MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2's Selective NMDA Binding Mechanism of ActionAccesswire • Thursday
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug ResistanceAccesswire • Monday
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THCAccesswire • 07/15/24
MIRA Pharmaceuticals Announces Ketamir-2 Shows Promising Safety Profile in Comparison to Traditional Ketamine In Preclinical TestingPRNewsWire • 06/24/24
Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This YearPRNewsWire • 06/10/24
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled SubstancePRNewsWire • 05/29/24
MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine AnalogPRNewsWire • 05/21/24
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine AnalogPRNewsWire • 05/20/24
Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND SubmissionPRNewsWire • 04/02/24
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific AdvisorPRNewsWire • 03/21/24
MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence SimulationsPRNewsWire • 12/04/23
MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80%PRNewsWire • 11/29/23
MIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern TimePRNewsWire • 11/21/23
MIRA Pharmaceuticals Announces Paradigm-Shift in Cognitive Enhancement with MIRA1aPRNewsWire • 11/21/23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2PRNewsWire • 11/20/23
MIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than PotPRNewsWire • 09/18/23
MIRA Pharmaceuticals and MZ Group Partner to Strengthen Investor Relations and Shareholder Communication EffortsPRNewsWire • 09/05/23
MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development SummitPRNewsWire • 08/31/23